TP53 and neoplasm: In another instance, mice with mutant KRAS and deletion of TP53 in lung tissue developed highly aggressive lung cancer, but the concurrent expression of the same NF-κB pathway inhibitor, IκB “super repressor”, significantly reduced both tumor count and size [49].